Veeva Systems (VEEV) Hits New 12-Month High and Low at $79.15
Veeva Systems (NYSE:VEEV)’s share price reached a new 52-week high and low during trading on Monday . The stock traded as low as $79.15 and last traded at $77.79, with a volume of 29118 shares. The stock had previously closed at $78.28.
Several equities research analysts have recently issued reports on the stock. Canaccord Genuity raised their price target on shares of Veeva Systems from $70.00 to $75.00 and gave the stock a “buy” rating in a research note on Wednesday, February 28th. Zacks Investment Research lowered shares of Veeva Systems from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, May 1st. Stifel Nicolaus raised their price target on shares of Veeva Systems from $67.00 to $70.00 and gave the stock a “buy” rating in a research note on Wednesday, February 28th. Morgan Stanley raised their price target on shares of Veeva Systems from $72.00 to $76.00 and gave the stock an “overweight” rating in a research note on Thursday, March 1st. Finally, DA Davidson assumed coverage on shares of Veeva Systems in a research note on Friday, February 2nd. They set a “buy” rating and a $75.00 price target for the company. Five analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $72.23.
The company has a market cap of $10.98 billion, a price-to-earnings ratio of 82.26, a P/E/G ratio of 4.67 and a beta of 1.40.
In related news, SVP Jonathan Faddis sold 2,462 shares of Veeva Systems stock in a transaction that occurred on Wednesday, March 7th. The shares were sold at an average price of $75.78, for a total value of $186,570.36. Following the completion of the transaction, the senior vice president now directly owns 1,073 shares in the company, valued at approximately $81,311.94. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Frederic Lequient sold 2,875 shares of Veeva Systems stock in a transaction that occurred on Monday, March 5th. The shares were sold at an average price of $71.72, for a total transaction of $206,195.00. Following the completion of the transaction, the senior vice president now owns 2,875 shares of the company’s stock, valued at $206,195. The disclosure for this sale can be found here. Insiders sold a total of 157,733 shares of company stock valued at $12,034,360 over the last quarter. 15.97% of the stock is owned by company insiders.
A number of institutional investors have recently added to or reduced their stakes in the stock. We Are One Seven LLC grew its position in shares of Veeva Systems by 147.6% during the 1st quarter. We Are One Seven LLC now owns 1,679 shares of the technology company’s stock valued at $123,000 after purchasing an additional 1,001 shares in the last quarter. Cerebellum GP LLC purchased a new position in shares of Veeva Systems during the 4th quarter valued at $129,000. Next Century Growth Investors LLC purchased a new position in shares of Veeva Systems during the 1st quarter valued at $130,000. American International Group Inc. purchased a new position in shares of Veeva Systems during the 4th quarter valued at $142,000. Finally, Northwestern Mutual Wealth Management Co. grew its position in shares of Veeva Systems by 154.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,176 shares of the technology company’s stock valued at $176,000 after purchasing an additional 1,927 shares in the last quarter. Institutional investors and hedge funds own 73.84% of the company’s stock.
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, and internationally. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, which allow pharmaceutical and biotechnology companies to target and support sales and marketing to physicians, other healthcare professionals, and healthcare organizations through various touch points, including in-person, email, and online; and Veeva Vault, a cloud-based enterprise content management platform and suite of applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, and quality.
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.